Dr. Garden's laboratory is currently developing a novel therapeutic for the treatment of Myasthenia Gravis in companion animals. In order to evaluate the effectiveness of a new treatment, the first step is to develop a reliable way to evaluate the severity of disease in each patient so that response to therapy can be measured.
Penn Vet is seeking dogs with myasthenia gravis for a blood collection study. The goal is to identify a bio-marker in patients with this disease that can be measured over time.
Eligible dogs will receive a neurological examination at the first visit, an acetylcholine receptor antibody titer, and a $50 gift card for participation. Participation in this study will contribute to research that has the potential to improve methods of diagnosis and prognosis of Myasthenia Gravis in veterinary patients.
For more information, please contact Ali Carroll at the Veterinary Clinical Investigations Center at 215-573-0302 or e-mail email@example.com.